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Abstract
Purpose—To examine maternal smoking and body mass index (BMI) interactions in 
contributing to risk of oral clefts.
Methods—We studied 4935 cases and 10,557 controls from 6 population-based studies and 
estimated a pooled logistic regression of individual-level data, controlling for study fixed effects 
and individual-level risk factors.
Results—We found a significant negative smoking-BMI interaction, with cleft risk with smoking 
generally declining with higher BMI. For all clefts combined, the OR for smoking was 1.61 (95% 
CI: 1.39–1.86) at BMI 17 (underweight), 1.47 (95% CI: 1.34–1.62) at BMI 22 (normal weight), 
1.35 (95% CI: 1.22–1.48) at BMI 27 (overweight), 1.21 (95% CI: 1.04–1.41) at BMI 33 (obese), 
and 1.13 (95% CI: 0.92–1.38) at BMI 37 (very obese). A negative interaction was also observed 
for isolated clefts and across cleft types but was more pronounced for cleft lip only and cleft palate 
only.
Conclusions—Our findings suggest that the risk of oral clefts associated with maternal smoking 
is largest among underweight mothers, although the smoking-BMI interaction is strongest for cleft 
lip only and cleft palate only. BMI was not protective for the effects of smoking; a clinically 
relevant increase in smoking-related cleft risk was still present among heavier women.
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Introduction
Oral clefts continue to be one of the most prevalent birth defects, affecting close to 1/700 
births on average. Of all the environmental factors that might contribute to the risk of oral 
clefts, maternal smoking is the most well established (1) and was considered a causal factor 
for oral clefts in the 2014 US Surgeon General’s Report (2). Other factors such as body mass 
index (BMI) have also been supported in recent studies. Another consistent risk factor is 
BMI. Obese mothers have elevated risks of children with oral clefts compared with normal-
weight mothers (3).
No prior study has examined whether the risk of oral clefts associated with smoking is 
moderated by BMI. There are several reasons why such an interaction may exist, although 
the direction of the interaction is theoretically ambiguous. On one hand, each of these risk 
factors may reinforce the effects of the other. Smoking may exacerbate metabolic problems 
(4, 5), while maternal obesity may modify the activity of drug metabolizing enzymes such as 
CYP1A1 (6). Furthermore, both maternal smoking and obesity increase the risk of placental 
insufficiency (7–9). Even though the placenta is not fully functional until after clefts form, 
early synergetic and adverse effects of these risk factors on placental function could 
potentially exacerbate the risk of clefts.
On the other hand, carrying one risk factor may simply reduce the relative importance of the 
other for cleft risk. For instance, the added risk of clefts due to smoking may be lower 
among obese mothers who themselves have a higher risk for clefting due to metabolic 
problems. There may also be mechanistic interactions that offset the risk of one factor in the 
presence of the other. Among smokers, the interactions between lipophilic carcinogens and 
DNA (DNA adducts) were reported to be lower with higher BMI (10). One may also 
hypothesize that, all else being equal, higher BMI provides a greater fat tissue volume for 
storing cigarette chemicals such as PAHs or dioxins, thus potentially delaying fetal exposure 
to their metabolites during the critical first few weeks of pregnancy when clefts form. Some 
support for an offsetting interaction in another context comes from observational studies 
reporting a lower lung cancer risk among smokers with increasing BMI (11). Similarly, other 
studies reported that smoking was associated with an elevated risk of postmenopausal breast 
cancer only in non-obese but not in obese women (12), and that smoking was related to 
higher cancer-related mortality among underweight young women than among women with 
higher weight (13).
We examined the interaction between maternal smoking and pre-pregnancy BMI as they 
influence the risk of oral clefts. Using data from a large international consortium of six 
population-based case-control studies, we evaluated whether the association of first-trimester 
smoking with oral clefts varies by BMI. Understanding this heterogeneity may help to 
accurately quantify the contributions of these risk factors to oral clefts.
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Methods
Data
Our study combined samples from six population-based studies of oral clefts. Each study 
provided a sample of cases with oral clefts and controls and included detailed data on 
environmental risk factors during the first trimester through maternal interviews(1). Together 
the studies provide a sample of 4935 cases and 10557 controls. We did not exclude any case 
enrolled in the participating studies based on whether the cleft was isolated or non-isolated 
(occurring with other birth defects or syndromes), although alternative analyses focused on 
isolated clefts as described below. Cases with known syndromes were not enrolled in the 
NBDPS.
The Iowa Child Health Study (ICHS) identified cases with clefts through active, state-wide 
surveillance of births by the Iowa Registry for Congenital and Inherited Disorders between 
1987 and 1991 and randomly selected non-malformed controls from Iowa birth certificates 
during the same time period providing a total sample of 280 cases and 293 controls (14). 
The Utah Child and Family Health Study (UCFHS) identified cases through state-wide 
surveillance and randomly selected controls from Utah birth certificates between 1995 and 
2004 providing a total analytical sample of 557 cases and 658 controls (15). The National 
Birth Defects Prevention Study (NBDPS) identified cases through surveillance programs in 
10 US states between 1997 and 2007 and randomly selected controls from birth certificates, 
providing a total analytical sample of 3277 cases and 7834 controls (16). Cases with clefts 
from Utah were enrolled beginning in 2005, with no overlap between the NBDPS and 
UCFHS. The Norway Facial Clefts Study (NFCS) identified cases with clefts born between 
1996 and 2001 through national registries from centralized cleft repair centers. Controls 
were randomly selected from all Norwegian births in the same period, providing a total 
analytical sample of 559 cases and 754 controls (17). The Norwegian National Mother and 
Child Cohort Study (MoBa) enrolled a population-based cohort of about 100,000 
pregnancies in 1999–2009 (18), from which births with clefts were selected as well as a 
random sample of controls for a total analytical sample of 280 cases and 293 controls. The 
Danish National Birth Cohort (DNBC) is also a population-based sample of 100,000 
pregnancies from Denmark in 1997–2003, providing an analytical sample of 123 cases and 
592 controls (19, 20).
Outcomes and Risk Factors
Because smoking has been shown to be related to the three cleft types (cleft lip, cleft lip with 
palate, and cleft palate only) both combined and individually (1), we first examined any cleft 
including isolated and non-isolated cases (i.e. occurring with other birth defects), and then 
isolated cases alone, in order to maximize the power of our analysis. We also considered 
each of the three cleft types separately, pooling isolated and non-isolated cases and then 
including only isolated cases. We evaluated any active maternal smoking during the first 
trimester of pregnancy. In additional analyses, we considered dose, separating smokers into 
non-smokers, low smokers (≤ 4 cigarettes/day) and moderate-to-heavy smokers (≥ 5 
cigarettes per day) (1). We classified mothers based on their pre-pregnancy BMI [(weight in 
kg)/(height in m)2] into underweight (BMI<18.5), normal weight (18.5≤BMI<25), 
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overweight (25≤BMI<30), and obese (BMI ≥30). Smoking and pre-pregnancy maternal 
height and weight were measured through maternal surveys using comparable questions 
across the studies (1).
Statistical Analysis
Our analysis was based on the pooled dataset of the six studies while accounting for any 
potential differences between the study populations and case-control ratios as noted below. 
We used logistic regression with case-control status as the outcome to examine the 
interaction between smoking and BMI. We estimated a logistic regression for case-control 
status that included any smoking (yes/no), BMI as a continuous measure, and their 
interaction. The model also adjusted for any maternal alcohol consumption and use of folic-
acid-containing supplements in the first trimester, and age (≤18, 19–25, 26–30, 31–35, and 
≥36 years), an indicator for low maternal education (incomplete high school versus higher 
education), and dummy variables representing the 6 contributing studies. These study-
specific fixed effects account for differences among the study populations in oral cleft risk 
factors, prevalence, time effects, and case-to-control ratios (1, 3, 21). These fixed effects, as 
well as the balancing of cases and controls by year of birth within each study, ensured that 
time is not a confounder in the pooled analysis. We did not control for diabetes because it 
can be a consequence of obesity. Furthermore, prior work has shown that it did not 
meaningfully account for the associations of BMI with risk of oral clefts (3).
Results
Table 1 provides the counts of cases by cleft type as well as smoking rates and BMI 
distributions for cases and controls. The sample included 4935 cases with clefts (including 
4041 cases with isolated clefts) and 10557 controls. Among cases, 1134 had cleft lip only, 
2078 had cleft lip with palate, and 1723 had cleft palate only. As reported in prior studies (1, 
3), smoking, underweight, and obesity rates were higher among cases than controls.
Table 2 presents the results from the logistic regressions examining interactions between 
smoking and BMI across the various cleft groups. Both smoking and BMI were associated 
with an increase in oral cleft risk on their own, although risks were not significantly elevated 
(at p<0.05) for certain cleft types. There was a significant negative interaction between the 
two risk factors, in that the increase in risks of any oral cleft with smoking declined as BMI 
increased. For any cleft (isolated and non-isolated), the ORs were 2.18 (95% CI: 1.49–3.17) 
for smoking, 1.13 (95% CI: 1.05–1.21) per 10 BMI units, and 0.84 (95% CI: 0.72–0.97) for 
the smoking-BMI interaction. Because the OR for the smoking-BMI interaction term is not 
directly interpretable, we derived the ORs for smoking at various BMI levels (Figure 1) to 
illustrate the magnitude of the interaction. The OR for smoking was 1.61 (95% CI: 1.39–
1.86) at BMI 17 (underweight), 1.47 (95% CI: 1.34–1.62) at BMI 22 (normal weight), 1.35 
(95% CI: 1.22–1.48) at BMI 27 (overweight), 1.21 (95% CI: 1.04–1.41) at BMI 33 (obese), 
and 1.13 (95% CI: 0.92–1.38) at BMI 37 (very obese). Similar results were observed for any 
isolated cleft.
This negative interaction was more pronounced for cleft lip only and cleft palate only. The 
interaction was smaller and insignificant for cleft lip with cleft palate. For cleft lip only 
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(combining isolated and non-isolated cases), the ORs were 3.03 (95% CI: 1.53–6.00) for 
smoking, 1.09 (0.96–1.24) for 10 BMI units, and 0.75 (0.57–0.99) for the smoking-BMI 
interaction. When evaluated at specific BMI levels, the smoking OR was 1.86 (95% CI: 
1.44–2.39) at BMI 17, 1.61 (95% CI: 1.36–1.90) at BMI 22, 1.39 (95% CI: 1.17–1.65) at 
BMI 27, 1.17 (95% CI: 0.88–1.55) at BMI 33, and 1.04 (95% CI: 0.71–1.53) at BMI 37 
(Figure 1). For cleft palate only (isolated and non-isolated), the comparable ORs were 2.23 
(1.27–3.93), 1.17 (1.05–1.29) and o.82 (0.65–1.02); the smoking OR was 1.58 (95% CI: 
1.27–1.96) at BMI 17, 1.43 (95% CI: 1.23–1.65) at BMI 22, 1.29 (95% CI: 1.12–1.48) at 
BMI 27, 1.14 (95% CI: 0.91–1.43) at BMI 33, and 1.05 (95% CI: 0.77–1.43) at BMI 37 
(Figure 1). Results were similar when considering isolated clefts, but the smoking risk and 
interaction with BMI interaction were more pronounced for isolated cleft palate only.
Discussion
Maternal smoking is widely considered one of the most unequivocal environmental risk 
factors for oral clefts. Previous studies have focused mainly on average associations, with 
little exploration of possible heterogeneity in risk across other factors. We examined the 
heterogeneity in smoking associations with oral cleft risk by maternal BMI, another risk 
factor. We found that the increase in the risk of oral clefts associated with maternal smoking 
generally declines with increasing maternal BMI, with the largest risk from smoking among 
underweight mothers and the lowest risk among obese mothers. This is the first study to 
report this interaction for oral clefts. When examining cleft types separately, the trend was 
strongest for cleft lip only and cleft palate only, and much weaker for cleft lip with palate. 
This suggests further heterogeneity in the relationship between maternal smoking and BMI 
by cleft type. Our findings suggest that the relative importance of smoking and BMI 
generally declines as the risk from the other factor increases although this interaction has 
further heterogeneity with respect to cleft type. Such an interaction may occur because of 
reduction in DNA adducts with higher BMI among smokers (10), or potential reduction in 
fetal exposure to cigarette chemicals in the critical weeks of cleft formation with greater 
storage of these chemicals in maternal fat tissue. Our findings should not be interpreted as 
suggesting that smoking is harmless to the fetuses of obese women. Despite the ORs of 
smoking being much reduced among obese women, their magnitude was still clinically 
relevant (Figure 1).
Our study has several strengths including the large population-based samples and a pooled 
individual-level analysis that controls for several potential confounders. However, 
unmeasured confounding cannot be excluded as an alternative explanation for the interaction 
effect as noted above. For instance, it is possible that the observed interaction is capturing an 
overall nutritional effect with increasing BMI, such as reduced food insecurity, which has 
been linked to cleft palate (22). It is worth noting however that our results are robust to 
adjustments for the individual-level risk factors described above, which is reassuring when 
considering both unmeasured and residual confounding (Supplementary Table S1). 
Furthermore, there are alternative approaches to examine the interaction between smoking 
and BMI such as stratifying by BMI levels or evaluating combinations of smoking and BMI 
levels. These approaches, however, are less powerful than the above-described model that 
directly tests the smoking-BMI interaction. Nonetheless, these alternative models provide 
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generally consistent results with our main model (Supplementary Tables S2 and S3), 
although power dramatically declines in these models because of the stratified samples and 
multiple smoking-BMI groups, thus limiting our ability to statistically test this interaction.
The findings highlight the complexity of pathways for risk of oral clefts. Ignoring potential 
interactions between risk factors may result in average risk estimates that are not 
representative across population subgroups defined by other risk factors. Examining these 
interactions can shed light on the population-level contributions of risk factors to oral clefts. 
Exposure to passive smoke has also been associated with increased risk of oral clefts(1). 
Future research examining interactions between maternal active smoking, passive smoke, 
and BMI may shed further light on the etiology of oral clefts. Also, investigations of the 
mechanisms through which interactions between smoking and BMI operate are needed to 
understand how these two common factors contribute to the etiology of oral clefts.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. ORs for First-Trimester Maternal Smoking by Pre-Pregnancy BMI Derived from 
Logistic Regression Including Smoking-BMI Interaction
Notes: ORs for smoking were estimated at BMI levels from 15 to 40 in increments of 1 unit. 
Isolated and non-isolated clefts are combined.
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Table 1
Cleft Type and First Trimester Smoking and Pre-Pregnancy BMI Distribution by Case-Control Status in 
Analytical Sample
Cases Controls
N % N %
Total Sample 4935 100 10557 100
Any Cleft 4935 100 - -
  Cleft Lip Only 1134 23.0 - -
  Cleft Lip with Palate 2078 42.1 - -
  Cleft Palate Only 1723 34.9 - -
Any Cleft Isolated 4041 100 - -
  Cleft Lip Only 1029 25.5 - -
  Cleft Lip with Palate 1740 43.1 - -
  Cleft Palate Only 1272 31.5 - -
Smoking 4935 100 10557 100
  Yes 1177 23.9 1908 18.1
  No 3758 76.2 8649 81.9
BMI Categories 4935 100 10557 100
  Underweight 308 6.2 565 5.4
  Normal weight 2642 53.5 5821 55.1
  Overweight 1136 23.0 2502 23.7
  Obese 849 17.2 1669 15.8
Notes: Rates were rounded to 1 decimal.
Ann Epidemiol. Author manuscript; available in PMC 2018 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Wehby et al. Page 10
Ta
bl
e 
2
Lo
gi
sti
c 
Re
gr
es
sio
n 
fo
r O
ra
l C
le
fts
 In
cl
ud
in
g 
In
te
ra
ct
io
ns
 b
et
w
ee
n 
Fi
rs
t-T
rim
es
te
r M
at
er
na
l S
m
ok
in
g 
an
d 
Pr
e-
Pr
eg
na
nc
y 
BM
I
C
le
ft 
St
at
us
Sm
ok
in
g
BM
I├
Sm
ok
in
g 
× 
BM
I├
O
R
†
95
%
 C
I
O
R
†
95
%
 C
I
O
R
†
95
%
 C
I
P-
Va
lu
e
Is
ol
at
ed
 an
d 
no
n-
Is
ol
at
ed
 C
lef
ts
 
 
A
ny
 C
le
ft
2.
18
1.
49
3.
17
1.
13
1.
05
1.
21
0.
84
0.
72
0.
97
0.
02
 
 
 
 
Cl
ef
t l
ip
 O
nl
y
3.
03
1.
53
6.
00
1.
09
0.
96
1.
24
0.
75
0.
57
0.
99
0.
04
 
 
 
 
Cl
ef
t L
ip
 w
ith
 
 
 
 
Pa
la
te
1.
84
1.
11
3.
04
1.
13
1.
02
1.
24
0.
90
0.
74
1.
09
0.
28
 
 
 
 
Cl
ef
t P
al
at
e 
O
nl
y
2.
23
1.
27
3.
93
1.
17
1.
05
1.
29
0.
82
0.
65
1.
02
0.
07
Is
ol
at
ed
 C
lef
ts
 
 
A
ny
 C
le
ft
2.
26
1.
51
3.
36
1.
11
1.
03
1.
19
0.
84
0.
72
0.
98
0.
03
 
 
 
 
Cl
ef
t l
ip
 O
nl
y
3.
15
1.
56
6.
36
1.
07
0.
94
1.
23
0.
76
0.
57
1.
01
0.
06
 
 
 
 
Cl
ef
t L
ip
 w
ith
 
 
 
 
Pa
la
te
1.
52
0.
89
2.
60
1.
07
0.
97
1.
19
0.
98
0.
79
1.
21
0.
84
 
 
 
 
Cl
ef
t P
al
at
e 
O
nl
y
3.
20
1.
66
6.
14
1.
18
1.
05
1.
32
0.
71
0.
55
0.
92
0.
01
N
ot
es
:
† M
ul
tiv
ar
ia
bl
e 
lo
gi
sti
c 
re
gr
es
sio
n 
m
od
el
 a
dju
ste
d f
or,
 
m
at
er
na
l e
du
ca
tio
n 
(le
ss 
tha
n h
igh
 sc
ho
ol 
de
gr
ee
 v
er
su
s 
hi
gh
er
 e
du
ca
tio
n),
 m
ate
rna
l a
ge
 (≤
18
, 1
9–
25
, 2
6–
30
, 3
1–
35
, 3
6–
49
yrs
), a
ny
 a
lc
oh
ol
 u
se
 
(Y
es
/N
o) 
an
d f
oli
c a
cid
 us
e(Y
es
/N
o) 
as 
we
ll a
s s
tud
y d
um
my
 va
ria
bl
es
. A
 se
pa
ra
te
 re
gr
es
sio
n 
is 
es
tim
at
ed
 fo
r e
ac
h 
cl
ef
t g
ro
up
.
├ B
M
I i
s e
x
pr
es
se
d 
in
 1
0 
un
its
.
Ann Epidemiol. Author manuscript; available in PMC 2018 February 01.
